Jane L. Wang

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 335 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor

Gabriel Mbalaviele, Adele M. Pauley, Alexander F. Shaffer et al. · Biochemical Pharmacology · 2010 · 64 citations

Life Sciences, Biochemistry, Pharmacology +11

Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein

Emily J. Reinhard, Jane L. Wang, Richard C. Durley et al. · Journal of Medicinal Chemistry · 2003 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate

Jane L. Wang, Jeffery Carter, James R. Kiefer et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates

Jane L. Wang, Karl Aston, David C. Limburg et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12